T1	Participants 712 769	interferon monotherapy relapsers with chronic hepatitis C
T2	Participants 90 153	interferon alpha monotherapy relapsers with chronic hepatitis C
T3	Participants 779 842	Interferon alpha monotherapy relapsers with chronic hepatitis C
T4	Participants 1308 1452	Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm
T5	Participants 1454 1506	Baseline characteristics were similar in both groups
